Biomedical imaging research opportunities workshop IV: A white paper

Medical Physics

Volumn 34, Issue 2, 2007, Pages 673-679

  Hendee, William R ^a   Banovac, Filip ^b   Carson, Paul L ^c   DeFronzo, Ralph A ^d   Eckelman, William C ^e   Fullerton, Gary D ^f   Larson, Steven M ^g   McLennan, Gordon ^h   Welch, Michael J ^h  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e Molecular Tracer LLC   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g INDIANA UNIVERSITY   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic disease; Diabetes; Drug development; Image guided therapy; Imaging research; Imaging technology; Rodents

Indexed keywords

DISEASE CONTROL; MAMMALS; MEDICAL IMAGING; MEDICAL PROBLEMS;

CHRONIC DISEASE; DRUG DEVELOPMENT; IMAGE GUIDED THERAPY; IMAGING TECHNOLOGY; RODENTS;

IMAGING SYSTEMS;

CONFERENCE PAPER; DIABETES MELLITUS; DIAGNOSTIC IMAGING; HUMAN; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; RESEARCH; RODENT;

RODENTIA;

EID: 33846607281     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2405838     Document Type: Conference Paper

References (73)

1. P. L. Carson, " Biomedical Imaging Research Opportunities Workshop: Report and recommendations., " Radiology 229, 328-339 (2003).
2. C. L. Partain, " Biomedical Imaging Research Opportunities Workshop II: Report and recommendations., " Radiology 236, 389-403 (2005).
3. W. R. Hendee and G. S. Gazelle, " Biomedical Imaging Research Opportunities Workshop III: A white paper., " Ann. Biomed. Eng. 34, 188-198 (2006).
4. E. Zerhouni, " Medicine. The NIH Roadmap., " Science 302, 63-72 (2003).
5. M. P. Kung and H. F. Kung, " Mass effect of injected dose in small rodent imaging by SPECT and PET., " Nucl. Med. Biol. 32, 673-678 (2005).
6. E. M. Jagoda, " Experiment assessment of mass effects in the rat: Implications for small animal PET imaging., " Nucl. Med. Biol. 31, 771-779 (2004).
7. C. S. Levin, " Primer on molecular imaging technology., " Eur. J. Nucl. Med. Mol. Imaging 32, Suppl. 2, S325-S345 (2005).
8. A. Y. Nikitin, " Classification of proliferative pulmonary lesions of the mouse: Recommendations of the mouse models of human cancers consortium., " Cancer Res. 64, 2307-2316 (2004).
9. P. L. Chow, " A method of image registration for small animal, multimodality imaging., " Phys. Med. Biol. 51, 379-390 (2006).
10. A. J. Chaudhari, " Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging., " Phys. Med. Biol. 50, 5421-5441 (2005).
11. S. Nikolaus, " State-of-the-art of small animal imaging with high-resolution SPECT., " Nuklearmedizin 44, 257-266 (2005).
12. G. Zacharakis, " Fluorescent protein tomography scanner for small animal imaging., " IEEE Trans. Med. Imaging 24, 878-885 (2005).
13. P. Novak, " Experience with a small animal hyperthermia ultrasound system (SAHUS): Report on 83 tumours., " Phys. Med. Biol. 50, 5127-5139 (2005).
14. L. W. Dobrucki and A. J. Sinusas, " Molecular cardiovascular imaging., " Curr. Cardiol. Rep. 7, 130-135 (2005).
15. S. K. Lyons, " Advances in imaging mouse tumour models in vivo., " J. Pathol. 205, 194-205 (2005).
16. M. Rodriguez-Porcel, " Image-guided cardiac cell delivery using high-resolution small-animal ultrasound., " Mol. Ther. 12, 1142-1147 (2005).
17. F. H. Fahey, " Evaluation of the quantitative capability of a high-resolution positron emission tomography scanner for small animal imaging., " J. Comput. Assist. Tomogr. 28, 842-848 (2004).
18. E. E. Graves, R. Weissleder, and V. Ntziachristos, " Fluorescence molecular imaging of small animal tumor models., " Curr. Mol. Med. 4, 419-430 (2004).
19. M. L. Li, " A digital ultrasonic system for small animal imaging., " Ultrason. Imaging 26, 85-99 (2004).
20. Y. Yang, " Optimization and performance evaluation of the microPET II scanner for in vivo small-animal imaging., " Phys. Med. Biol. 49, 2527-2545 (2004).
21. B. A. Klaunberg and M. J. Lizak, " Considerations for setting up a small-animal imaging facility., " Lab Anim. 33, 28-34 (2004).
22. H. Barthel, P. Price, and E. O. Aboagye, " Small-animal imaging of tumour proliferation with PET., " Lancet 5, 100 (2004).
23. J. M. Park and S. S. Gambhir, " Multimodality radionuclide, fluorescence and bioluminescence small-animal imaging., " Proc. IEEE 93, 771-783 (2005).
24. M. G. Pomper and J. S. Lee, " Small animal imaging in drug development., " Curr. Pharm. Des. 11, 3247-3272 (2005).
25. J. L. Tatum and J. M. Hoffman, " Congressional update: Report from the Biomedical Imaging Program of the National Cancer Institute. Imaging drug development., " Acad. Radiol. 7, 1007-1008 (2000).
26. A. Louie, " Design and characterization of magnetic resonance imaging gene reporters., " Methods Mol. Med. 124, 401-417 (2006).
27. M. D. Silva and S. Chandra, " MRI in preclinical drug development., " Methods Mol. Med. 124, 299-322 (2006).
28. U. Haberkorn and M. Eisenhut, " Molecular imaging and therapy: A program based on the development of new biomolecules., " Eur. J. Nucl. Med. Mol. Imaging 32, 1354-1359 (2005).
29. W. C. Eckelman, J. A. Frank, and M. Brechbiel, " Theory and practice of imaging saturable binding sites., " Invest. Radiol. 37, 101-106 (2002).
30. W. C. Eckelman, " Are there lessons to be learned from drug development that will accelerate the use of molecular imaging probes in the clinic?, " Nucl. Med. Biol. 32, 657-662 (2005).
31. W. K. Schiffer, " Imaging addiction with PET: Is insight in sight? " Drug Discovery Today 10, 547-562 (2005).
32. G. J. Kelloff, " The progress and promise of molecular imaging probes in oncologic drug development., " Clin. Cancer Res. 11, 7967-7985 (2005).
33. P. M. Smith-Jones, " Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors., " Nat. Biotechnol. 22, 701-706 (2004).
34. F. Sams-Dodd, " Target-based drug discovery: Is something wrong? " Drug Discovery Today 10, 139-147 (2005).
35. B. J. Druker, " Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia., " N. Engl. J. Med. 344, 1031-1037 (2001).
36. B. Ravina, " The role of radiotracer imaging in Parkinson disease., " Neurology 64, 208-215 (2005).
37. K. A. Frey, " Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging., " Ann. Neurol. 40, 873-884 (1996).
38. R. J. Genco, " A proposed model linking inflammation to obesity, diabetes, and periodontal infections., " J. Periodontol. 76, Suppl. 11, 2075-2084 (2005).
39. E. Reisin and M. A. Alpert, " Definition of the metabolic syndrome: Current proposals and controversies., " Am. J. Med. Sci. 330, 269-272 (2005).
40. L. Kappeler and J. Epelbaum, " Biological aspects of longevity and aging., " Rev. Epidemiol. Sante Publique 53, 235-241 (2005).
41. G. C. Fonarow, " An approach to heart failure and diabetes mellitus., " Am. J. Cardiol. 96, 47E-52E (2005).
42. C. M. Goeddeke-Merickel, " The goals of comprehensive and integrated disease state management for diabetic kidney-disease patients., " Adv. Chronic Kidney Dis. 12, 236-242 (2005).
43. M. Rijken, " Comorbidity of chronic diseases: Effects of disease pairs on physical and mental functioning., " Qual. Life Res. 14, 45-55 (2005).
44. S. Goya Wannamethee, " Overweight and obesity and the burden of disease and disability in elderly men., " Int. J. Obes. Relat. Metab. Disord. 28, 1374-1382 (2004).
45. S. M. Marshall, " Recent advances in diabetic nephropathy., " Clin. Lab Med. 4, 277-282 (2004).
46. Z. T. Bloomgarden, " Consequences of diabetes: Cardiovascular disease., " Diabetes Care 27, 1825-1831 (2004).
47. J. B. Meigs, " Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus., " J. Am. Med. Assoc. 291, 1978-1986 (2004).
48. M. W. Stolar and R. J. Chilton, " Type 2 diabetes, cardiovascular risk, and the link to insulin resistance., " Clin. Ther. 25, Suppl B, B4-B31 (2003).
49. G. Paolisso, " Cardiovascular risk in type 2 diabetics and pharma-cological regulation of mealtime glucose excursions., " Diabetes Metab. 29, 4 Pt 1, 335-340 (2003).
50. V. Marks, " The metabolic syndrome., " Nurs. Stand 17, 37-44 (2003).
51. A. P. Harmel, " Treating diabetes: Cardiovascular benefits of antidiabetes drugs., " Am. J. Manag. Care 8, Suppl. 8, S219-S228 (2002); A. P. Harmel, " Treating diabetes: Cardiovascular benefits of antidiabetes drugs., " Am. J. Manag. Care 8, Suppl. 8, quiz S229-S232 (2002).
52. A. P. Harmel, " Treating diabetes: Cardiovascular benefits of antidiabetes drugs., " Am. J. Manag. Care 8, Suppl. 8, S219-S228 (2002); A. P. Harmel, " Treating diabetes: Cardiovascular benefits of antidiabetes drugs., " Am. J. Manag. Care 8, Suppl. 8, quiz S229-S232 (2002).
53. E. Ravussin and C. Bouchard, " Human genomics and obesity: Finding appropriate drug targets., " Eur. J. Pharmacol. 410, 131-145 (2000).
54. H. Keen, C. Clark, and M. Laakso, " Reducing the burden of diabetes: Managing cardiovascular disease., " Diabetes/Metab. Rev. 15, 186-196 (1999).
55. M. J. Franz, " Managing obesity in patients with comorbidities., " J. Am. Diet Assoc. 98, 10 Suppl 2, S39-S43 (1998).
56. R. N. Foley, P. S. Parfrey, and M. J. Sarnak, " Epidemiology of cardiovascular disease in chronic renal disease., " J. Am. Soc. Nephrol. 9, Suppl. 12, S16-S23 (1998).
57. E. Rossi, " Cardiovascular disease in diabetes and operative risk., " Rays 22, 595-602 (1997).
58. D. E. Dupuy, " Tumor ablation: Treatment and palliation using image-guided therapy., " Oncology 19, 11 Suppl. 4, 4-5 (2005).
59. M. Oldham, " Cone-beam-CT guided radiation therapy: A model for on-line application., " Radiother. Oncol. 75, 271-278 (2005).
60. F. A. Jolesz, " MR imaging-controlled focused ultrasound ablation: A noninvasive image-guided surgery., " Magn. Reson Imaging Clin. N. Am. 13, 545-560 (2005).
61. E. J. Halpern, " Science to practice: High-intensity focused ultrasound ablation: Will image-guided therapy replace conventional surgery? " Radiology 235, 345-346 (2005).
62. J. T. Yap, " Image-guided cancer therapy using PET/CT., " Cancer J. 10, 221-233 (2004).
63. D. Tomazevic, " 3D/2D registration of CT and MR to x-ray images., " IEEE Trans. Med. Imaging 22, 1407-1416 (2003).
64. K. G. Vosburgh and F. A. Jolesz, " The concept of image-guided therapy., " Acad. Radiol. 10, 176-179 (2003).
65. P. Jannin, " Validation of medical image processing in image-guided therapy., " IEEE Trans. Med. Imaging 21, 1445-1449 (2002).
66. A. H. Chan, " An image-guided high intensity focused ultrasound device for uterine fibroids treatment., " Med. Phys. 29, 2611-2620 (2002).
67. D. Y. Chan, " Image-guided therapy in urology., " J. Endourol 15, 105-110 (2001).
68. J. Kettenbach, " Interventional and intraoperative magnetic resonance imaging., " Annu. Rev. Biomed. Eng. 2, 661-690 (2000).
69. R. S. Hinks, " MR systems for image-guided therapy., " J. Magn. Reson Imaging 8, 19-25 (1998).
70. D. H. Gronemeyer, " Two- and three-dimensional imaging for interventional MRI and CT guidance., " Stud. Health Technol. Inform. 29, 62-76 (1996).
71. R. Leemuller, R. Bendl, and W. Schlegel, " Image-guided therapy planning for interventional stereotactic therapy of brain tumors., " Radiologe 36, 737-743 (1996).
72. M. W. Vannier and J. L. Marsh, " Three-dimensional imaging, surgical planning, and image-guided therapy., " Radiol. Clin. North Am. 34, 545-563 (1996).
73. F. Laerum, " Demand for a new main speciality in image-guided therapy., " Comput. Methods Programs Biomed. 66, 81-85 (2001).